Scinovex
articleTop 1% cited

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

Nature Cell Biology · 2002 · Vol. 4(9) · pp. 648–657
Ken InokiYong LiTianquan ZhuJun WuKun‐Liang Guan
Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancerPolyamine Metabolism and ApplicationsTSC2TSC1PI3K/AKT/mTOR pathwayProtein kinase BPhosphorylationP70-S6 Kinase 1RHEBCell biologymTORC1RPTOR

MeSH terms

Tuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 ProteinBinding SitesCarrier ProteinsCell LineHumansInsulinModels, BiologicalMutationPhosphoproteinsPhosphorylationProtein KinasesProteinsProto-Oncogene ProteinsRepressor Proteins

Funding

  • National Institutes of Health
Citations
3,038
FWCI
46.70
field-weighted impact
References
50
Percentile
100%
vs. same field & year
Citations per year
Cited by
mTOR: a pharmacologic target for autophagy regulation
Journal of Clinical Investigation · 2015 · 2,079 citations
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
International Journal of Molecular Sciences · 2017 · 1,137 citations
Mechanisms of Insulin Action and Insulin Resistance
Physiological Reviews · 2018 · 2,790 citations
mTOR signaling at a glance
Journal of Cell Science · 2009 · 2,135 citations
A complex interplay between Akt, TSC2 and the two mTOR complexes
Biochemical Society Transactions · 2009 · 710 citations
Related articles
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.